BiotechTube

Nanatinostat + Valganciclovir + Pembrolizumab

Phase 1Terminated
0 watching 0 views this week💤 Quiet
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Nasopharyngeal Carcinoma

Conditions

Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma, EBV Related Carcinoma, EBV-Related Sarcoma

Trial Timeline

Oct 8, 2021 → Jan 10, 2025

NCT ID
NCT05166577

About Nanatinostat + Valganciclovir + Pembrolizumab

Nanatinostat + Valganciclovir + Pembrolizumab is a phase 1 stage product being developed by Viracta Therapeutics for Nasopharyngeal Carcinoma. The current trial status is terminated. This product is registered under clinical trial identifier NCT05166577. Target conditions include Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05166577Phase 1Terminated

Competing Products

20 competing products in Nasopharyngeal Carcinoma

See all competitors
ProductCompanyStageHype Score
Cisplatin 2 + Docetaxel + Cisplatin 1Sun PharmaceuticalPhase 2
52
CisplatinSun PharmaceuticalPhase 3
77
Cisplatin 1 + Cisplatin 2 + Docetaxel + XelodaSun PharmaceuticalPhase 3
77
5-fu + Lobaplatin + Placebo + leucogenSun PharmaceuticalPhase 3
77
CapecitabineSun PharmaceuticalPhase 3
77
Amifostine every-other-day regimen + Amifostine everyday regimenSun PharmaceuticalPhase 2
52
Nedaplatin + CisplatinSun PharmaceuticalPhase 3
77
PD-1 blocking antibody + Gemcitabine + Cisplatin (80 mg/m2) + Cisplatin (100 mg/m2) + CapecitabineSun PharmaceuticalPhase 3
77
QL1706 + Gemcitabine + CisplatinSun PharmaceuticalPhase 3
77
The combination treatment of anlotinib, penpulimab and capecitabine.Sun PharmaceuticalPhase 2
52
docetaxel, nedaplatin, and capecitabine + nedaplatin + docetaxel, cisplatin, and fluorouracil + cisplatin + docetaxel, cisplatin, and capecitabine + docetaxel, nedaplatin, and fluorouracilSun PharmaceuticalPhase 3
77
Pemetrexed (Alimta)Eli LillyPhase 2
52
Camrelizumab + Placebos + Gemcitabine + CisplatinJiangsu Hengrui MedicinePhase 3
77
Famitinib + CisplatinJiangsu Hengrui MedicinePhase 1
33
SHR-1210 + Gemcitabine + cis-platinumJiangsu Hengrui MedicinePhase 1
33
SHR-1701 + Gemcitabine + Cisplatin + Albumin PaclitaxelJiangsu Hengrui MedicinePhase 1
33
FamitinibJiangsu Hengrui MedicinePhase 2
52
ApatinibJiangsu Hengrui MedicinePhase 2
52
SHR-1210Jiangsu Hengrui MedicinePhase 2
52
SHR-1701 + FamitinibJiangsu Hengrui MedicinePhase 1/2
41

Other Products from Viracta Therapeutics

Nanatinostat in combination with valganciclovirPhase 2
44
[14C]-Nanatinostat + Nanatinostat (free base) tablets in combination with Valganciclovir + Nanatinostat mesylate tablets in combination with Valganciclovir + Single-agent Nanatinostat (free base) tabletsPhase 1
25